Navigo Proteins GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Navigo Proteins GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11526
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Navigo Proteins GmbH (Navigo Proteins), formerly Scil Proteins GmbH, a subsidiary of UV-Cap GmbH & Co KG, is a protein engineering company that offers generation and optimization of proteins for therapeutic and non-therapeutics. The company provides microbial production of recombinant proteins. Its business areas include development of drug conjugates oncology indications, multi-specific protein binding molecules, and ligands for non-therapeutic applications. Navigo Proteins develops Affilin, a based molecules are derived from a human scaffold protein for generation of radio conjugates. The company serves pharmaceutical, biotech and life science industries. Navigo Proteins is headquartered in Halle, Germany.

Navigo Proteins GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navigo Proteins GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Navigo Proteins GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
UV-Cap Acquires Scil Proteins from Bionet Ventures 11
Partnerships 12
Natrix Separations Enters into Co-Development Agreement with Scil Proteins 12
Isotopen Technologien Munchen and Scil Proteins Enter into Partnership 13
Ono Pharma Enters Into Co-Development Agreement With Scil Proteins For Affilin Therapeutics 14
Navigo Proteins GmbH – Key Competitors 15
Navigo Proteins GmbH – Key Employees 16
Navigo Proteins GmbH – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navigo Proteins GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navigo Proteins GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Navigo Proteins GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
UV-Cap Acquires Scil Proteins from Bionet Ventures 11
Natrix Separations Enters into Co-Development Agreement with Scil Proteins 12
Isotopen Technologien Munchen and Scil Proteins Enter into Partnership 13
Ono Pharma Enters Into Co-Development Agreement With Scil Proteins For Affilin Therapeutics 14
Navigo Proteins GmbH, Key Competitors 15
Navigo Proteins GmbH, Key Employees 16

List of Figures
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navigo Proteins GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Navigo Proteins GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Navigo Proteins GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Primeline Energy Holdings Inc (PEH):企業の財務・戦略的SWOT分析
    Summary Primeline Energy Holdings Inc (Primeline Energy) is an upstream company that explores oil and gas. The company acquires and explores crude oil and natural gas properties across China. It owns and operates exploration and development rights in two offshore blocks in the East China Sea. Primel …
  • Mylan NV (MYL):製薬・医療:M&Aディール及び事業提携情報
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines, and consumer healthcare products. It offers pharmaceutical products in multiple forms for various disease conditions related to respiratory and allerg …
  • Marshall of Cambridge (Holdings) Ltd:戦略・SWOT・企業財務分析
    Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Bucher Industries AG:企業の戦略・SWOT・財務情報
    Bucher Industries AG - Strategy, SWOT and Corporate Finance Report Summary Bucher Industries AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tokyo Tatemono Co., Ltd.:企業の戦略・SWOT・財務情報
    Tokyo Tatemono Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokyo Tatemono Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Bunzl plc (BNZL):医療機器:M&Aディール及び事業提携情報
    Summary Bunzl plc (Bunzl) is a global distribution and outsourcing company. The company offer its customers with a unique business concept, which provides individual solutions along the supply chain to a variety of businesses and numerous goods around the world. It supplies a broad range of non-food …
  • Canam Group Inc:企業の戦略的SWOT分析
    Canam Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Airbnb Inc:企業の戦略・SWOT・財務情報
    Airbnb Inc - Strategy, SWOT and Corporate Finance Report Summary Airbnb Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Chubu Electric Power Co Inc (9502)-エネルギー分野:企業M&A・提携分析
    Summary Chubu Electric Power Co Inc (Chubu) is an energy utility. It generates and procures electricity; and offers electric network related services. The company produces electricity from nuclear, hydro, solar, biomass, wind, coal, fuel oil, and natural gas sources. Chubu has interests in upstream …
  • Qiagen NV (QIA):企業の財務・戦略的SWOT分析
    Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Austevoll Seafood Asa:企業の戦略・SWOT・財務分析
    Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report Summary Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Pep BoysManny, Moe & Jack:企業の戦略・SWOT・財務情報
    The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report Summary The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Acobiom:企業の製品パイプライン分析2018
    Summary Acobiom is a biotechnology company that specializes in biomarker discovery and development of innovative diagnostics. The company undertakes the discovery of RNA and DNA biomarkers, which finds application in the areas of disease detection and classification, patient stratification, companio …
  • Biosynex SA (ALBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Biosynex SA (Biosynex), formerly All Diag Sarl is an in-vitro diagnostic company that manufactures, research, and develops rapid diagnostic tests. The company offers rapid diagnostic kits for diagnostic applications; and designing, self-measurement, and distributing thermometers. It offers t …
  • Toyota Industries Corp (6201):企業の財務・戦略的SWOT分析
    Toyota Industries Corp (6201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Dubai Electricity and Water Authority:発電所・企業SWOT分析
    Dubai Electricity and Water Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Excelsior Gold Limited (EXG):企業の財務・戦略的SWOT分析
    Excelsior Gold Limited (EXG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cholamandalam Investment and Finance Company Ltd (CHOLAFIN):企業の財務・戦略的SWOT分析
    Cholamandalam Investment and Finance Company Ltd (CHOLAFIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the comp …
  • Western Farmers Electric Cooperative:発電所・企業SWOT分析
    Western Farmers Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Metgasco Ltd (MEL):企業の財務・戦略的SWOT分析
    Summary Metgasco Ltd (Metgasco) is an oil and gas exploration company. The company that acquires, explores, produces, and develops oil and gas, petroleum and hydrocarbon assets. It holds interests in Clarence Moreton Basin, an exploration license located in northern New South Wales. Metgasco supplie …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆